Your browser doesn't support javascript.
loading
Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase.
Suzuki, Takanori; Michihata, Nobuaki; Aso, Shotaro; Yoshikawa, Tetsushi; Saito, Kazuyoshi; Matsui, Hiroki; Fushimi, Kiyohide; Yasunaga, Hideo.
Afiliación
  • Suzuki T; Department of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.
  • Michihata N; Department of Pediatrics, Fujita Health University, Aichi, Japan.
  • Aso S; Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. michihata@m.u-tokyo.ac.jp.
  • Yoshikawa T; Department of Biostatistics & Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Saito K; Department of Pediatrics, Fujita Health University, Aichi, Japan.
  • Matsui H; Department of Pediatrics, Fujita Health University, Aichi, Japan.
  • Fushimi K; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
  • Yasunaga H; Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Eur J Pediatr ; 180(11): 3279-3286, 2021 Nov.
Article en En | MEDLINE | ID: mdl-33973071
ABSTRACT
Kawasaki disease (KD) is an acute systemic vasculitis that most commonly causes acquired cardiac disease in children in developed countries. The most highly recommended treatment for KD is 2 g/kg intravenous immunoglobulin (IVIG). There are two types of IVIG, sodium-containing (high-Na) and sodium-trace (low-Na) preparations. However, few studies have compared the effects of these two preparations for superiority. The purpose of this study was to compare outcomes between high and low-Na IVIG preparations in KD children using a national inpatient database in Japan. We used the Diagnostic Procedure Combination database to identify KD patients treated with IVIG between 2010 and 2017. We identified those receiving high and low-Na preparations of IVIG as an initial treatment. Outcomes included proportion of coronary artery abnormalities (CAA), IVIG resistance, adverse effects, length of stay, and medical cost. Propensity score-matched analyses were conducted to compare the outcomes between the two groups. Instrumental variable analyses were performed to confirm the results. We identified 42,345 patients with KD. There were significant differences in proportions of CAA (2.8% vs. 3.2%; p = 0.031) and IVIG resistance (17% vs. 18%, p = 0.001) between the two groups. However, there were no significant differences in length of stay or medical cost. The instrumental variable analysis confirmed the same results as the propensity score analysis.

Conclusion:

The present study suggests that high-Na IVIG is potentially effective for reducing the proportion of CAA in KD patients. Prospective studies are warranted to confirm the effectiveness observed in this study. What is Known • For treatments of Kawasaki Disease in acute phase, intravenous immunoglobulin have been the most recommended to reduce fever early and prevent complications of coronary artery abnormalities. There are two types of IVIG preparations, sodium-containing IVIG and sodium-trace IVIG. However, few studies have performed comparisons to determine which preparation of IVIG is superior. What is New • The present findings suggest that high-Na IVIG is associated with reductions in the proportions of CAAs and IVIG resistance in KD patients.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Síndrome Mucocutáneo Linfonodular Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans / Infant Idioma: En Revista: Eur J Pediatr Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Síndrome Mucocutáneo Linfonodular Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans / Infant Idioma: En Revista: Eur J Pediatr Año: 2021 Tipo del documento: Article País de afiliación: Japón